Test Price
2,800 AED✅ Home Collection Available
MECP2 Gene (Autism Susceptibility, X-Linked Type 3) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MECP2 (قابلية التوحد، النوع 3 المرتبط بـ X) بتقنية التسلسل الجيني NGS في الإمارات | 2800 درهم | دليل هيئة الصحة بدبي 2026
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHA-licensed clinicians.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Laboratory Licence: 9834453
ملخص تنفيذي:
يُقدِّم هذا الفحص تسلسل جين MECP2 الكامل بدقة تصل إلى 99.9% من خلال مختبر معتمد وفقًا لمعايير الآيزو، مع خدمة سحب الدم المنزلي المتميزة عبر تقنية النقل المبردة. يتضمن توجيهًا سريريًا بعد الفحص عبر الهاتف، ودعمًا للتحقق من التأمين الصحي عبر واتساب. يُجرى في دولة الإمارات وفقًا لأحدث المبادئ التوجيهية الصادرة عن هيئة الصحة بدبي لعام 2026.
تحليل متوافق تمامًا مع المرسوم بقانون اتحادي رقم 41 لسنة 2024 (المادة 87) وقانون سلامة بيانات الطفل (CDS 2026) وقانون حماية البيانات الشخصية في الإمارات.
Compliant with UAE Federal Decree-Law No. 41/2024 (Art. 87), Child Data Safety Law (CDS 2026), and UAE PDPL.
Overview
The MECP2 Genetic Test screens for mutations in the MECP2 gene associated with autism spectrum susceptibility, Rett syndrome, and X-linked intellectual disability type 3. Performed via next-generation sequencing, it delivers comprehensive analysis of the entire coding region, enabling precise clinical correlation and family planning.
يقوم تحليل جين MECP2 بتقنية التسلسل الجيني الشامل بالكشف عن الطفرات المرتبطة بقابلية التوحد ومتلازمة ريت والإعاقة الذهنية المرتبطة بالكروموسوم X، مما يوفر معلومات دقيقة للتشخيص والإرشاد الوراثي.
| Feature | Our Test (MECP2 NGS) | Closest Alternative |
|---|---|---|
| Methodology | NGS Full Gene Sequencing | Targeted Mutation Panel (PCR) |
| Diagnostic Sensitivity | 99.9% (ISO 9001:2015 Validated) | ~85% (limited to known hotspots) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Pre‑Test Requirements: A detailed clinical history and a mandatory genetic counselling session to draw a pedigree chart of affected family members must be completed before sample collection.
Physician Insight & Safety Protocol
From Dr. Prabhakar Reddy (DHA: 61713011), Consultant Neurologist: “Pursuing genetic testing for autism susceptibility can understandably evoke strong emotions. This test offers vital molecular clarity, yet it is essential that results are interpreted within the full clinical picture by a qualified neurologist or clinical geneticist. Our team remains dedicated to supporting your family with empathy and expertise at every turn.”
⚠ Medication Warning: Do not discontinue any prescribed medications or alter treatment plans without first consulting your doctor.
Safety Exclusion Criteria
- Patients with severe bleeding disorders (e.g., haemophilia) require specialist clearance.
- Unstable medical conditions that could compromise safe blood collection.
- Inability to provide informed consent (or guardian consent for minors) in accordance with UAE CDS 2026.
- Pregnant individuals should discuss test implications with their obstetrician.
Emergency Red Flags – Seek Immediate Medical Attention
- Sudden loss of speech or motor skills (regression).
- Breathing irregularities, apnea, or hyperventilation.
- Prolonged or new‑onset seizures.
- Severe lethargy or unresponsiveness.
Frequently Asked Questions
What is the MECP2 gene test and who should consider it?
MECP2 genetic testing identifies mutations causing Rett syndrome and autism susceptibility in children with neurological signs. This test is recommended for children presenting with developmental regression, loss of purposeful hand skills, speech delay, or atypical autism features, especially when a family history of X‑linked disorders is noted. A clinical geneticist or pediatric neurologist can best determine eligibility.
يقوم تحليل جين MECP2 بتحديد الطفرات المسببة لمتلازمة ريت وقابلية التوحد لدى الأطفال الذين تظهر عليهم علامات عصبية.
How is the test performed and what is the turnaround time?
Blood or DNA sample analyzed via Genetic Test teleconsultation.
يتم تحليل عينة الدم أو الحمض النووي عبر تقنية NGS وتظهر النتائج خلال 3-4 أسابيع.
Is genetic counseling required before testing?
Yes, a pre‑ genetic counseling session is mandatory to review family history and explain potential outcomes. UAE regulations (CDS 2026 for minors) and DHA guidelines require that all patients and guardians receive a dedicated counseling session. During this session, a certified genetic counselor will construct a pedigree, discuss the inheritance pattern, and outline the implications of possible results (pathogenic, benign, or variants of uncertain significance). This step empowers families to make informed decisions.
نعم، يجب عقد جلسة استشارة وراثية قبل الفحص لمراجعة التاريخ العائلي وشرح النتائج المحتملة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians